SiBio requests suspension of Abbott’s preliminary injunction in EU member state markets in UPC order
MLex Summary: SiBio, a medical technology startup, has requested to suspend the impact of provisional measures imposed by Abbott Diabetes Care Inc., a prominent glucose-monitoring technology provider, in an order from...To view the full article, register now.
Already a subscriber? Click here to view full article